Th e aims of this study are to determine anticardiolipin antibodies in patients with Sy Behcet and to determine correlation between the levels of anticardiolipin antibodies in serum in patients with clinic systemic and ocular manifestations. Th e study was conducted on  patients with Behcet disease (group I), and on  healthy subjects (group II). Anticardiolipin antibodies -aCL were determined by the standard ELISA method, where GPL=  microgram/ml IgG aCL and  MPL=  microgram/ ml IgM, and were considered negative <  GPL or MPL, low positive (- GPL and MPL), or high positive (> GPL and MPL). In the group of  patients with the diagnosis Sy Behcet,  of them were (.) with values of anticardiolipin antibodies over  positive. In the control group of the healthy examinees aCl were positive in  cases (.). Th ere are no statistically signifi cant diff erences in the presence of systemic clinic characteristics between aCl positive and negative patients. All the patients with SY Behcet in whom anticardiolipn antibodies were found have extremely severe visual damage which is not present in the group of those patients where the values of aCl were low. Th e diff erence is statistically signifi cant. Th e level of anticardiolipin antibodies is increased in the patients with Behcet. Th ere are no statistically signifi cant diff erences in the presence of systemic clinical characteristics between aCL positive and negative patients. Visual acuity in patients with SY Behcet is statistically signifi cantly much lower in patients who had increased values of aCL.
Introduction
Behcet's disease is a multi -system disease named after the Turkish dermatologist Dr. Hulusi Behcet (-), who described the triad of symptoms in , such as eye infl ammation, oral and genital ulcers [, ] . Th e diagnosis of this disease is mostly based on clinical fi ndings. Th e criteria for diagnosis were established by Th e Behcet's Disease Research Committee of the Ministry of Health and Welfare of Japan. According to this classifi cation there are major and minor criteria. Major criteria are: eye infl ammation, recurrent oral aphthous mucosa, genital ulcerations and skin lesions: erythema nodosum, thrombophlebitis and cutaneous hypersensitivity. Minor criteria are: arthritis, digestive duct ulceration, epididymitis, and vascular diseases: obliteration, vessel occlusion, aneurisma and neuropsychiatric symptoms. Depending on the criteria present, there are complete, incomplete, suspect and possible types. Th e complete type has four major features occurring either simultaneously or at diff erent times. Th e incomplete type involves three major features, or typical ocular disease with one major criterion. Th e suspect type is diagnosed when two major features without ocular manifestation are present. The possible type involves one major feature and possibility to develop the other ones [, ] . Ocular manifestations -eye involvement in  - of these patients is the most dreaded complication [, ] . Th e disease can aff ect both posterior and anterior eye pole, with certain characteristic signs. A very common fi nding is anterior uveitis or iridocyclitis, with hypopyon and can be seen in / of these patients. Damage of the retina is the most difficult aspect of the disease and, as a consequence, can lead to severe visual damage. Basically, recurrent occlusions of retinal vessels lead to irreversible changes. Other ocular manifestations include episcleritis, fi lamentous keratitis, conjunctivitis and subconjunctival haemorrhage. Paralysis of extraocular muscles can be the result of neuro-Behcet's [,] . The basis of histopathological lesions in Behcet's disease is perivasculitis with tissue destruction [] . It was thought that the basic mechanism leading to histological changes was immune complex deposition, because deposition of complement components was proved in some lesions [,] . Also, the role of T cells, as a basic mechanism of cell damage in Sy Behcet, has been considered [] . In recent years many authors' attention has been drawn to the presence of anticardiolipin antibodies in patients with Behcet's disease. Since recurrent thrombosis, thrombocytopenia and frequent vasculitis are common manifestations of Behcet's disease, there is a need to search for anticardiolipin antibodies in serum in these patients [, ] . Th ey paid special attention to the connection between clinical manifestations and titra anticardiolipin antibodies in serum [, , ] . Anticardiolipin antibodies belong to a subgroup of antiphospholipid antibodies [, , ] . The occurrence of these antibodies has been associated with arterial and venous thrombosis, fetal loss, thrombocytopenia, a number of neurological disorders (Guillain-Barre Syndrome, migraine, chorea) and several systemic diseases (SLE, Lyme disease, Syphilis) [, ] . It seems likely that the major clinical features associated with raised levels of anticardiolipin antibodies are more commonly found when the antibodies are of the IgG isotype. Anticardiolipin antibodies of the IgM type are not very informative, since they were also present in ten percent of the healthy controls [, ] . The aims of the study were to determine the presence of anticardiolipin antibodies in patients with Sy Behcet and to determine the correlation between the level of anticardiolipin antibodies in serum of the patients and retinal vascular complications.
Materials and Methods
Patients Th e study enrolled  patients with Sy Behcet-group I. Th e patients fulfilled International criteria for Behcet's disease and did not have any other disease at the same time. Group II enrolled  healthy patients.
Laboratory analysis
Anticardiolipin antibodies were performed at the Immunology Laboratory of Children's Internal Clinic. Anticardiolipin antibodies -aCl were determined by the standard ELISA-methods. Levels for aCL-a and aG-PI-a and for IgG and IgM were measured by commercially used enzyme tubes. One GPL is defined as binding activity of  microgram/ml IgG aCL-a, and MPL is defined as binding activity of  microgram/ml IgM. Results of aCL-a are expressed by standard units for IgG (GPL) and for IgM (MPL) and were considered to be negative if <  GPL or MPL, low positive ( - GPL and MPL), or high positive ( >  GPL and MPL). Test results were considered to be positive if there were more than  units for IgG -aGPI and  standard units for IgM for GPI for IgMGPI.
Statistical analysis
To evaluate the connection between the presence of clinical features (systemic or ocular changes) and the presence of antiocardiolipin antibodies (aCL) in patients with Sy Bechet, we used Fischer's exact test and Cohen's kappa (κ) value.
Results
The group I enrolled  patients,  male and  female, average age , years. Eight patients (.) had changes in both eyes, and in  patients (.) there was one side form (a total of  eyes). (Table ) .
Out of  observed eyes,  (.) had serious or expressed form of ocular inflammation. As for visual acuity,  eyes (.) had acuity less than < ., nine eyes (.) had visual acuity <., two eyes (.) < . and only one eye (.) had visual acuity .. Hypopyon is recorded in  (.) eyes and it is not a constant sign. Its characteristic is fast onset, but it can withdraw in one day. All  eyes had opacitates in vitreous part. Wrapping of retinal veins was found in  eyes, that is .. Occlusion of retinal veins was found in  (.) eyes. Th is sign is statistically signifi cantly the most common one in this group. Changes in blood vessels of optic disc were found in  (.) eyes, while in two eyes in thermal stadiums there was atrophy of optic disc. Retinal haemorrhages were found in  eyes (.), neovascularisation in  (.) eyes, while cystoid macular edema was registered in  (.) eyes. In the group of  patients with the diagnosis Sy Behcet there were  of them (.) with anticardiolipin antibodies values over  (positive). In the control group,  out of  healthy subjects were aCL positive (.) Table ) .
Involvement of blood vessels PNO is present as a clinical characteristic in all patients who were aCL " +" ( or ) , while in the group aCL " -" it is much less present ( or  Retinal blood vessels occlusion is present as a clinical feature in great number of patients who are aCL " +", while in group aCL " -" it is much less present. But this difference is not statistically significant. Our results are mostly the same as the results of the others ophthalmologist, and most of them also couldn't find statistical significance in their investigations. We only found the statistical significance in correlation of visual acuity and presence of anticardiolipin antibodies. Takay et al. [] in their study of  patients with Behcet's disease used standard ELISA method for aCL. IgG was found in , IgM in . of the patients, IgA in .. They did not find statistical significance compared to the control group. Also, there were no correlations with any isotopes or any clinical manifestations. It is interesting that the same authors found great statistical significance between titra IgA aCL-a in patients with HLA-B negative patients and control group, while this was not found in patients who were HLA-B positive. Kang et al. [] showed in his study that anticardiolipin antibodies were found in , patients with BD, , had uveitis, , vitritis, and retinal vasculitis was found in , patients. Priori et al. [] found Ig-aCL in  patients with Behcet's disease who had ocular disorders as well, while patients treated with corticosteroids had low titre anticardiolipin antibodies. Ang et al. [] found in their study IgG-aCL  with IgM, and  with both IgG and IgM, and they emphasized signifi cantly great relation between the presence of aCl-a and retinal vasculitis. Kim WU et al. [] found in their study high IgM -aCL titar in patients who predominantly had skin manifestations and erythema nodosum. Apart from this study, there were no correlations with any specific manifestations of Behcet's disease and titra antibodies, especially thrombosis, more than expected. It is interesting that there is signifi cantly lower average frequency of aCl-. in patients from Turkey, compared to other studies where it is averagely .. Th is can be explained by methodological diff erences such as  SD,  SD,  SD which are accepted above average in normal subjects, who are positive in diff erent serials, what can aff ect obtained data. Alternatively, regional diff erences, whether environmental or genetics, can also have an impact on the presence of aCLa, as they also have an impact on other antibodies [,] . Differences in clinical manifestations in patients with Sy Behcet in different countries were also noted. Similarly, positive test HLA B was more frequent among the patients from the countries where the disease itself is more frequent (Turkey, Japan), compared to patients from Europe [] . All in all, the problem with this type of analysis is the fact that the countries the studies come from do not necessarily show the ethnicity of the patients. Different values can be a consequence of more factors: adjusting the time of investigation, therapy management. Difference in findings by different authors is probably the result of different technical approaches for measurement of aCL-a, so there is an urgent need to standardise aCl tests.
Conclusion
Level of anticardiolipin antibodies is increased in patients with Sy Behcet.There are no statistically significant differences in the presence of systemic clinical characteristics between aCL positive and negative patients. Visual acuity in patients with SY Behcet is statistically significantly much lower in patients who had increased values of aCL.
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